Verenigde Staten - Engels - NLM (National Library of Medicine)

avera mckennan hospital - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate 100 mg

Verenigde Staten - Engels - NLM (National Library of Medicine)

galderma laboratories, l.p. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg in 1 g - pliaglis cream is a combination of lidocaine, an amide local anesthetic, and tetracaine, an ester local anesthetic, and is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis cream is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4)]. - pliaglis cream is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. pregnancy category b. no adequate and well-controlled studies have been conducted in pregnant women. pliaglis cream should be used during pregnancy only if the potential benefit justifies risk to the fetus. lidocaine was not teratogenic in rats at doses up to 60 mg/kg (8-fold higher than the level of lidocaine contained

Australië - Engels - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - diltiazem hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hydrogenated castor oil; aluminium hydroxide; methacrylic acid copolymer; purified talc; magnesium stearate; titanium dioxide; indigo carmine; methylcellulose; macrogol 400 - moderate to severe angina pectoris due to atherosclerotic coronary artery disease or coronary artery spasm (vasospastic angina).

Verenigde Staten - Engels - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg in 1 g - pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - pliaglis is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on pliaglis use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. published data on tetracain

Armenië - Engels - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis consumer health s.a. - dimethindene maleate, phenylephrine - spray nasal - 0,25mg/ml+2,5mg/ml

Armenië - Engels - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis consumer health s.a. - dimethindene maleate, phenylephrine - drops nasal - 0,25mg/ml+2,5mg/ml

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - diltiazem hydrochloride -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - diltiazem hydrochloride -

Verenigde Staten - Engels - NLM (National Library of Medicine)

stat rx usa llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculo-skeletal conditions. the mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate does not directly relax tense skeletal muscles in man. contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardiospasm (megaesophagus) and myasthenia gravis. contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

Verenigde Staten - Engels - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate extended-release tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculo skeletal conditions. contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (megaesophagus) and myasthenia gravis. contraindicated in patients who have demonstrated a previous hypersensitivity to the drug. orphenadrine has been chronically abused for its euphoric effects.[1] the mood elevating effects may occur at therapeutic doses of orphenadrine.[2]